Microbiota-associated metabolic reprograming influenced clinical outcome in the randomized dendritic cell-based clinical trial in stage III melanoma

Name: Microbiota-associated metabolic reprograming influenced clinical outcome in the randomized dendritic cell-based clinical trial in stage III melanoma
Creator: Déborah Suissa
Published: 2023-09-19T10:18:54.791Z
Keywords: Metabolomics

Suissa, Déborah; ALVES COSTA SiILVA, Carolina; Derosa, Lisa; Drubay, Damien; M. de Vries, Jolanda; Bol, Kalijn; Birebent, Roxanne; Fidelle, Marine; durand, sylvere; Sow, Cisse; Terrisse, Safae; Routy, Bertrand; Kroemer, Guido; Segata, Nicola; Zitvogel, Laurence; Piccinno, Gianmarco; Aprahamian, Fanny; Manghi, Paolo; eggermont, alexander; Bourgin, Mélanie; Schreibelt, Gerty; Pinto, Federica; Armanini, Federica; Asnicar, Francesco

doi:10.17632/nzb653783h.1

Microbiota-associated metabolic reprograming influenced clinical outcome in the randomized dendritic cell-based clinical trial in stage III melanoma

Published: 19 September 2023| Version 1 | DOI: 10.17632/nzb653783h.1

Contributors:

Déborah Suissa, Carolina ALVES COSTA SiILVA, Lisa Derosa, Damien Drubay, Jolanda M. de Vries, Kalijn Bol, Roxanne Birebent, Marine Fidelle, sylvere durand, Cisse Sow, Safae Terrisse, Bertrand Routy, Guido Kroemer, Nicola Segata, Laurence Zitvogel, Gianmarco Piccinno, Fanny Aprahamian, Paolo Manghi, alexander eggermont, Mélanie Bourgin, Gerty Schreibelt, Federica Pinto, Federica Armanini, Francesco Asnicar

Microbiota-associated metabolic reprograming influenced clinical outcome in the randomized dendritic cell-based clinical trial in stage III melanoma

Description

Files

Institutions

Categories

Licence